Efficacy of ivabradin to reduce heart rate prior to coronary CT angiography: comparison with beta-blocker
PDF
Cite
Share
Request
Cardiovascular Imaging - Original Article
P: 537-541
November 2012

Efficacy of ivabradin to reduce heart rate prior to coronary CT angiography: comparison with beta-blocker

Diagn Interv Radiol 2012;18(6):537-541
1. Department of Radiology, Atatürk University, Faculty of Medicine, Erzurum, Turkey
2. Department of Radiology, Atatürk University Faculty of Medicine, Erzurum, Turkey
3. Departments of Cardiology, Atatürk University School of Medicine, Erzurum, Turkey
4. Departments of Radiology, Atatürk University School of Medicine, Erzurum, Turkey
5. Kadir Has Üniversitesi Tıp Fakültesi, Radyodiagnostik Anabilim Dalı
6. Departments of Cardiology, Atatürk University School of Medicine, Erzurum, Turkey
7. Department of Diagnostic Radiology, University of Pamukkale, Denizli, Turkey
No information available.
No information available
Received Date: 02.05.2012
Accepted Date: 14.05.2012
PDF
Cite
Share
Request

ABSTRACT

PURPOSE

The objective of our study was to assess the effect of ivabradine on image quality of ECG-gated multidetector computed tomography (MDCT) coronary angiography.

MATERIALS AND METHODS

Computed tomography coronary angiography (CTCA) was performed on two groups. In Group 1 (n=54), an intravenous beta-blocker was administered to patients with a heart rate >70 beats per minute (bpm) just before CTCA. In Group 2 (n=56), oral ivabradine 5 mg was administered twice a day for three days prior to CTCA examination to patients with a heart rate >70 bpm and contraindication to beta-blockers. Images acquired on two different MDCT scanners were scored in terms of image quality of the coronary artery segments using a 5-point grading scale (Grade 1, unreadable; Grade 5, excellent).

RESULTS

The mean heart rates during CTCA were 64±6.7 bpm for Group 1 and 59±4.1 bpm for Group 2 (P < 0.05). Mean heart rate reduction was 9±5% and 14±8% for Groups 1 and 2, respectively (P < 0.001). A total of 880 segments were evaluated in 110 patients. When the best reconstruction interval was used, 89.8% and 95.5% of all the coronary segments showed acceptable image quality in Groups 1 and 2, respectively. Acceptable image quality of the middle right coronary artery was obtained in 78.3% of Group 1 and 92.4% of Group 2. These ratios for the other segments were 88.4% for Group 1 and 95.2% for Group 2.

CONCLUSION

Reduction of heart rates with ivabradine premedication improves the image quality of CTCA. It should be considered as an alternative drug, particularly in patients with contraindications to beta-blockers.